On May 18, 2026, CEO Geoff Ballotti announced he will undergo treatment for Multiple Myeloma but will continue working. Additionally, it was reported that Chief Accounting Officer Nicola Rossi will depart on July 31, 2026, with Christopher Androski set to replace him.